We serve Chemical Name:pyropheophytin a CAS:14409-87-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:pyropheophytin a
CAS.NO:14409-87-1
Synonyms:Pyrophaeophytin a
Molecular Formula:C53H72N4O3
Molecular Weight:813.16400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:999.9ºC at 760mmHg
Density:1.11g/cm3
Index of Refraction:1.58
PSA:99.67000
Exact Mass:812.56000
LogP:10.41370
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Pyrophaeophytin a chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyrophaeophytin a physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyrophaeophytin a Use and application,Pyrophaeophytin a technical grade,usp/ep/jp grade.
Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. pyropheophytin a manufacturer The continuous acceleration of the industrial transfer process has provided a huge market space for the fine chemical intermediate industry. pyropheophytin a supplier “The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said CEO Gabriele Brambilla in a statement. pyropheophytin a vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. pyropheophytin a factory At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.